Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 studyCéline Berthon, Hervé Dombret, Carlos Gomez‐Roca et al.|The Lancet Haematology|2016Cited by 431
Phase I dose-finding study of trabectedin (T) in combination with cisplatin (C) in patients (pts) with advanced solid tumors.C. Sessa, Luca Gianni, Elisa Gallerani et al.|Journal of Clinical Oncology|2011Cited by 0